Contact:
sales@biotechnologyforums.com to feature here

Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Biotech-Pharma Deal
#1
Dear all,

I am currently pursuing some market research regarding the synergy between Biotech and Pharma companies in pre-clinical stage deals and hence in the process of building a financial model. The recent Rib-x-Sanofi deal is a prime example.

The questions that I have are as follows:

1. What is the peak sales assumed for antibiotics and in how many years?
2. What are the royalty percentage we are looking at and is it on a tier basis?
3. What is the market trend for such pre-clinical stage deals?
4. Is all the upfront payment given in cash as widely reported or there are clauses attached to it?
5. What sort of discount rate do we use to value such deals?

Any help in this regard will be much appreciated.

Regards,
Niki
Like Post Reply
  

Possibly Related Threads…
Thread
Author
  /  
Last Post



Users browsing this thread:
1 Guest(s)

Biotech-Pharma Deal00